Wound dressing
Latest Bristol-Myers Squibb Company Patents:
- TREATMENT OF RENAL CELL CARCINOMA
- METHODS OF TREATING A TUMOR USING AN ANTI-PD-1 ANTIBODY
- Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-D3) pyridazine-3-carboxamide
- Galectin-3 inhibitors
- OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF
Description
The FIGURE is an elevational plan view of a wound dressing showing our new design.
Claims
We claim the ornamental design for a wound dressing, as shown and described.
Referenced Cited
Patent History
Patent number: D484602
Type: Grant
Filed: Aug 22, 2002
Date of Patent: Dec 30, 2003
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Bryan Griffiths (Chester), Helen Shaw (Widnes), Simon Adams (Holywell), Stephen Bishop (Deeside)
Primary Examiner: Stella Reid
Attorney, Agent or Law Firm: John M. Kilcoyne
Application Number: 29/166,184
Type: Grant
Filed: Aug 22, 2002
Date of Patent: Dec 30, 2003
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Bryan Griffiths (Chester), Helen Shaw (Widnes), Simon Adams (Holywell), Stephen Bishop (Deeside)
Primary Examiner: Stella Reid
Attorney, Agent or Law Firm: John M. Kilcoyne
Application Number: 29/166,184
Classifications
Current U.S. Class:
Bandage For Protection Or Treatment (53) (D24/189)
International Classification: 2404;
International Classification: 2404;
